Clinical Trial Update: Comparison of Orcinoside With Placebo in Treatment of MDD [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Orcinoside with placebo for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Orcinoside (Orcinoside)

Snippet

Sponsor: Shanghai Mental Health Center | Conditions: Major Depressive Disorder (MDD) | Phase 2 | Status: COMPLETED